Headache attributed to disorders of homeostasis …

Michael J Marmura MD

Headache & Pain

Updated 04.13.2026
Released 09.02.1994
Expires For CME 04.13.2029

Headache attributed to disorders of homeostasis

Author: Michael J Marmura MD

See Contributor Disclosures

Editor: Shuu-Jiun Wang MD

Cite this article

Headache attributed to disorders of homeostasis

In This Article

Quick Link

Introduction

Overview

Multiple medical problems, which upset our homeostatic equilibrium, may cause headache. This updated article on headaches attributed to disorders of homeostasis reviews both medical conditions, such as arterial hypertension or hypothyroidism, and external factors, such as high altitude or fasting, which commonly produce headache. Among the updates are new insights into the relationship between hypoxia and headache and new studies evaluating treatment options for acute chronic mountain sickness.

Key points

	• Dexamethasone, analgesics, metoclopramide, and preventive acetazolamide are among the effective treatments for high-altitude headache.
	• Hypertensive encephalopathy may trigger headache in association with arterial hypertension (higher than 180/120 mm Hg), especially in those with pheochromocytoma.
	• Hemodialysis may trigger headache, especially in those with increased predialysis blood pressure or blood urea nitrogen. Adjusting dialysis frequency and timing may prevent the complication.
	• Fasting is a trigger for headache or migraine, even in the absence of hypoglycemia. Preemptive frovatriptan may prevent migraine triggered by fasting.
	• Myocardial ischemia may trigger migraine-like headache, usually aggravated by exercise and relieved by treatment of angina.

Historical note and terminology

Headache attributed to a disorder of homeostasis, as defined by classification from the International Headache Society (49), includes headaches that occur during a metabolic disturbance and resolve after normalization. The major disorders of homeostasis known to cause headache are hypoxia or hypercapnia, hemodialysis, arterial hypertension, hypothyroidism, fasting, and cardiac cephalalgia.

This review does not consider headaches attributed to inflammatory or autoimmune disorders, infection, vascular disorders, seizures, increased or low cerebrospinal fluid pressure, and headache related to substances that may cause headache due to their use or withdrawal.

Clinical manifestations

Presentation and course

Headache attributed to hypoxia or hypercapnia. Headache caused by hypoxia or hypercapnia is defined as a headache that occurs when a patient has acute hypoxia with a PaO2 of 70 mm Hg or less or is chronically hypoxic, with PaO2 persistently at or below this level. It can occur at normal ambient oxygen pressures in patients with pulmonary disease, anemia, cardiac failure, carbon monoxide intoxication, or sleep apnea. Hypoxia may precipitate cluster and migraine headache in susceptible individuals.

Headache associated with acute carbon monoxide exposure occurs when carboxyhemoglobin levels rise above 20%; it is accompanied by nausea, vomiting, confusion, and dizziness. Seizures and coma develop when carboxyhemoglobin is greater than 40%, and death can occur when carboxyhemoglobin is greater than 60%. Acute carbon monoxide exposure is frequently followed by neuropsychiatric symptoms that may be disabling. Chronic exposure may cause headache due to activation of cyclic guanosine monophosphate and changes in nitric oxide signaling (05).

Some patients with hypercapnia develop severe headache, with or without papilledema in proportional to the degree of hypercapnia. The headache is throbbing, bilateral, and located mostly over the parietal, temporal, or occipital regions. It is usually associated with nausea and malaise, may last 10 minutes to a few hours, and is alleviated by reversing hypercapnia. Some patients with underlying pulmonary disease or sleep apnea may suffer from hypercapnia, and it is important to recognize its presentation, which includes headache, dry mouth, sore throat, and nocturia, because of the association of atrial fibrillation and sudden death (74; 35). Severe respiratory diseases, such as COVID-19, may worsen existing headache or precipitate de novo headache disease (11).

Acquired methemoglobinemia, usually related to medications in adults, may also precipitate headache (60).

Chronic hypoxia due to cabin depressurization may be a factor for astronauts who experience space headache (85). Space headache may present with features of migraine or tension-type headache and is more common in the first week of space travel (104).

High-altitude headache. High-altitude headaches are usually bilateral, dull or pressing in nature, and worsened by exertion, movement, and straining. Common descriptions include a pulsatile-burst type quality and "oscillating evolution" (90). In most people, headache begins at an altitude above 2500 meters within 24 hours of ascent. It increases in incidence at higher elevations and is more or less universal above 4500 m in non-acclimatized persons. A prospective study of high-altitude climbers demonstrated that headache developed in 83% of subjects (93). Headache onset occurs between 6 hours and 96 hours (sometimes as soon as 1 hour) after arrival at high altitude, and the headache can last 4 to 8 days. High-altitude headache is more common in patients with migraine and is often accompanied by phonophobia (93). The headache persists for hours or days without intervention or until the individual returns to lower altitudes. Risk factors for high-altitude headache include exertion, rapid ascent, poor fluid intake, a personal history of migraine (16), and possibly oral contraceptive use (48). Acclimatized, experienced mountaineers are less likely to develop high-altitude headache (53).

Headache is among several neurologic symptoms seen in those with acute mountain sickness. Acute mountain sickness (Lake Louise Consensus Group) occurs in nonacclimatized persons who arrive at a greater than 2500 meter altitude and is associated with one or more of the following symptoms (100):

• gastrointestinal symptoms: anorexia, nausea, or vomiting
• insomnia
• dizziness
• lassitude or fatigue
• lightheadedness

Sleep disturbances, including Cheyne-Stokes respiration and sleep apnea, often become prominent (83). Papilledema and retinal hemorrhages have been observed in some patients. Transient ischemic attacks or stroke (09), transient global amnesia (68), cerebral venous thrombosis (33), seizures (22), and cranial nerve palsies (107) are among the many potential significant neurologic presentations at high altitudes. High-altitude cerebral edema, presenting with global encephalopathy in a patient with acute mountain sickness, is considered to be the end stage of mountain sickness (111).

Chronic mountain sickness, also called Monge disease, develops in predisposed individuals living at high altitudes for a period of time. Chronic headache is a common symptom in addition to polycythemia, dizziness, tinnitus, sleep disturbance, fatigue, and mental confusion (88).

Diving headache. Diving, such as recreational scuba diving, can cause headache due to hypercapnia below 10 m, with increased intensity on resurfacing. Headache may occur independently of decompression sickness or "the bends," which typically presents with peripheral symptoms such as joint pain or arm or leg symptoms, occasionally due to spinal cord involvement. Severe headache associated with diving may signify arterial gas embolism, the second cause of mortality in divers, especially during rapid ascents (19). Any headache temporally related to scuba diving may signal an underlying neurologic disorder and should be taken seriously. Other common manifestations of cerebral arterial gas embolism are cognitive deficits, focal neurologic signs, and loss of consciousness (20).

Headache associated with fasting. Fasting commonly triggers headache, which may increase in intensity with the duration of the fast (76; 06). Fasting for religious reasons such as Yom Kippur (63) or Ramadan (06) may trigger diffuse headache or resemble migraine in those with a history of migraine. Fasting headache usually occurs without hypoglycemia.

Headache associated with dialysis. Headaches are a frequent complication of hemodialysis, with approximately 50% to 70% affected (03; 39). This phenomenon has also been observed in pediatric patients (45). Soon after the initiation of dialysis, some patients develop a dialysis disequilibrium syndrome consisting of headache, nausea, emesis, blurred vision, muscular twitching, and cramps. Disorientation, restlessness, and seizures may also occur. Onset of headache may be delayed with a mean onset of almost 3 hours and a mean duration of over 6 hours (40). In a long-term, prospective study of hemodialysis patients, dialysis headaches were typically frontotemporal in location, moderate in severity, and of short duration (lasting less than 4 hours) (39). The syndrome is self-limited, with recovery occurring within a few days. The headache symptoms in dialysis patients with a migraine history often resemble those of their previous migraine attacks. Risk factors for dialysis headache include weight change during dialysis sessions, arterial hypertension, or hypotension (39). Aggressive correction of the anemia associated with chronic renal disease and hemodialysis may cause headache, compared with partial correction of hemoglobin (81). The majority of persons with dialysis-related headache also have headaches with no temporal relationship to treatment (108).

Headache attributed to arterial hypertension. Headaches due to arterial hypertension include hypertensive crisis with or without encephalopathy, preeclampsia or preeclampsia, autonomic dysreflexia, and pheochromocytoma. Although these disorders have similar manifestations, such as a diffuse and pulsatile headache aggravated by physical exertion, their clinical presentations may vary considerably.

Headache attributed to hypertensive crisis with or without hypertensive encephalopathy. Acute changes in either systolic (higher than 180 mm Hg) or diastolic blood pressure (higher than 120 mm Hg) can trigger headache. Hypertensive emergency requires the presence of end-organ injury such as pulmonary edema and renal or heart failure, and may present with neurologic complications such as seizure, stroke, or delirium. Abnormalities on funduscopic examination, such as hemorrhages, papilledema, or exudates (cotton-wool spots), can be associated with encephalopathy (58). If the diagnosis is correct, signs of hypertensive encephalopathy, including headache, nausea, or confusion, should improve with lowering of blood pressure. Routine changes in blood pressure do not correlate with headache or migraine (62; 42), although there may be a modestly increased risk of headache in those with chronic hypertension (38).

Headache attributed to preeclampsia or eclampsia. New-onset headache in pregnancy, especially in the setting of new-onset hypertension and proteinuria, should raise concerns for preeclampsia (87). Headache is a common symptom in pregnancy and the postpartum period and is a common premonitory symptom of eclampsia. Unfortunately, the presence of headache is not a reliable predictor of poor outcomes or potential seizures (98). Over half of women who develop eclampsia have a history of migraine, which implicates migraine as an important risk factor for the disorder (31). In severe cases, eclampsia can lead to significant neurologic complications such as posterior reversible encephalopathy syndrome (26).

Headache attributed to autonomic dysreflexia. Autonomic dysreflexia is a condition in patients with cervical or upper thoracic spinal cord injuries in which noxious stimuli such as infection, pressure sores, burns, and bladder or bowel distention, infection, or blockage trigger increases in blood pressure, heart rate, sweating, and sudden severe throbbing headache (67). In patients with significant acute upper spinal cord injuries, the loss of descending sympathetic control significantly reduces blood pressure. Without this regulation, the sympathetic preganglionic neurons may reorganize to become hyperexcitable after the initial "shock," highly sensitive to peripheral input (61). Most patients with autonomic dysreflexia experience severe headache with other severe complications, including seizures, stroke, and death (34). Severe, sudden-onset headache in a patient with significant upper spinal cord injury should be assumed to be autonomic dysreflexia unless proven otherwise.

Headache attributed to pheochromocytoma. Headaches associated with pheochromocytoma tend to be severe but are usually paroxysmal and short-lasting rather than progressive or constant. Episodes usually last 10 minutes to 1 hour (70% of patients) and are often accompanied by other symptoms such as sweating, pallor, palpitations, or anxiety, including a sense of impending death (102). An abrupt rise in blood pressure that triggers headache is an important clue for further investigation.

Headache attributed to hypothyroidism. Headache is a common symptom in patients with hypothyroidism, affecting about 30% of those with the disorder (75). In one study, the mean time from the onset of hypothyroidism to the appearance of headache was 56 days (75). Headache resolves with appropriate replacement. Women with migraine and subclinical hypothyroidism also respond well to treatment (10). Despite these observations, one large trial indicated that high thyroid-stimulating hormone values are associated with a low prevalence of headache, most evident in women without a history of thyroid disease (46). Hypothyroidism and its treatment can be associated with pseudotumor cerebri and headache.

It should be mentioned that almost any significant endocrinopathy or metabolic disorder may cause headache, although for most disorders, there is insufficient evidence for a clear association. Hyperparathyroidism and Bartter syndrome, for example, present with hypokalemia, metabolic acidosis, high renin/aldosterone levels, and, often, headache (78; 80).

Headache attributed to airplane travel. Airplane headache is a distinct syndrome of short-lasting headache (usually less than 30 minutes) during airplane travel, typically during descent. The pain is nonspecific but is often unilateral, with few associated symptoms (71). The character of short-lasting but often severe headache attacks in airplane headache may be similar to headaches associated with rapid descent from high mountains and ascent during diving, suggesting a common mechanism (72). Space headache is another described headache disorder: in one study, 12 of 17 subjects reported new-onset headache during space flights (106).

Cardiac cephalalgia. Cardiac cephalalgia is a rare headache disorder that occurs during episodes of myocardial ischemia, usually but not always aggravated by exercise. Treatment with nitroglycerin or myocardial revascularization resolves headache (18). Although ischemia is the most common cause, a case report described the improvement of late-life migraine in a 63-year-old with supraventricular tachycardia and bradycardia after pacemaker implantation (73). Cardiac cephalgia may mimic migraine, and recognition is important for avoiding vasoconstrictive drugs such as triptans.

Other disorders of homeostasis. Although not specifically listed in the classification, many patients report headache in association with worsening of other medical disorders, such as anemia, hypoglycemia, or hyponatremia. If the headache resolves in temporal relationship to the medical condition, you may make the diagnosis of headache related to another disorder of homeostasis (49). Medical conditions may trigger other headache disorders, as seen with a case report of hypoglycemia causing hypnic headache (94). The presence of other medical conditions (eg, low blood sugar) may predict the emergence of headache disorders, such as postdural puncture headache (52).

Several studies have examined the relationship between metabolic syndrome, hyperglycemia, and migraine. Metabolic syndrome is associated with migraine in both clinic populations (70) and population-based studies (25). It is unclear if hyperglycemia is the cause of more severe or frequent migraine, or if migraine causes metabolic syndrome due to decreased physical activity or medications with side effects of weight gain.

Prognosis and complications

The prognosis and complications of headache depend on recognition and correction of the underlying homeostatic disorders. In some cases, such as high-altitude headache, the diagnosis is obvious, and symptoms resolve with treatment. In other disorders, such as dialysis headache, treatment of the underlying problem may be more difficult.

Clinical vignette

An otherwise healthy 47-year-old who sees you for migraine management wants to discuss her upcoming vacation: a 2-week hiking adventure with her family to the summit of Mount Kilimanjaro. Although physically fit, she is concerned about the chances of travel or altitude triggering migraine. The only daily medication she uses is amitriptyline 25 mg at night; she does not use oral contraceptives and rarely drinks alcohol. She takes sumatriptan 100 mg as needed with or without ibuprofen 600 mg depending on migraine severity. She is curious about why altitude triggers headache and wants to know what she can do to prevent or treat headache on her trip.

To decrease her risk of headache, you recommend a slow ascent with good hydration. You review symptoms of altitude sickness, such as dizziness, lightheadedness, nausea, and vomiting, which may require halting ascent. You also prescribe acetazolamide 250 mg twice daily starting 2 days before the ascent and for up to 7 days as a preventive measure, and dexamethasone 4 mg for acute headache unresponsive to sumatriptan or ibuprofen.

Biological basis

Etiology and pathogenesis

Hypoxic headaches. Mechanisms of high altitude or hypoxic headache include the following:

(1) Experimentally induced cerebral hypoxemia, especially when coupled with an increase in carbon dioxide tension in the blood, results in dilation of cerebral vessels, notably arteries and arterioles (112). Cerebral hypoxia leads to cerebral vasodilation, increased cerebral blood flow, altered endothelial and blood-brain barrier permeability, cerebral edema (43), and increased intracranial pressure. Cerebral hypoxia also causes a failure in ATP-dependent sodium pumps, which allows sodium and water to accumulate within brain cells (24). Furthermore, hypoxemia upregulates nitric oxide synthase, stimulates prostaglandin synthesis, and elevates anti-diuretic hormone levels, thus worsening brain swelling and increased intracranial pressure. Older age reduces the risk of headache at high altitudes, presumably due to brain atrophy (93). Common gene polymorphisms related to poor adaptation to hypoxia may also confer increased risk (92), suggesting the importance of genetic factors.

(2) Nocturnal periodic breathing with apnea or sleep apnea commonly occurs at high altitudes and results in hypercapnia, which may further increase cerebral blood flow and cerebral edema (101).

(3) Exercising in cold temperatures produces systemic hypertension that increases cerebral blood flow as autoregulation becomes impaired and worsens cerebral edema (24). Also, exercising in hypoxic conditions worsens cerebral oxygen desaturation.

(4) Hypoxia may induce cortical spreading depression and trigger release of nitroglycerin, calcitonin gene-related peptide, and adenosine, suggesting a link with migraine pathophysiology (32).

At high altitudes, altered brain compliance leads to a significant rise in CSF pressure in response to similar changes in cerebral blood flow. Narrowing of the transverse sinuses may predict hypoxemia and the development of headache at high altitudes (111). Retinal nerve fiber thickening, as measured by in optical coherence tomography, is common at high altitudes and appears to be a risk factor for high-altitude headache (113).

Headache associated with hypercapnia. Multiple pulmonary disorders that cause chronic hypoxia and hypercapnia are associated with headache, including asthma, chronic obstructive pulmonary disease, sleep apnea, and heart failure (79). Carbon dioxide relaxes vascular smooth muscle, potentially causing cerebral vasodilation, increased intracranial pressure, and headache. Hypercapnia is associated with increased generation of hydrogen ions (H+) that may cause nitric oxide-mediated vasodilation.

In carbon monoxide poisoning, the brain is edematous, and diffuse petechiae and hemorrhages are noted. The degree of edema and hemorrhage seems to correlate better with the degree of hypotension rather than hypoxia. Many of these changes in the brain are similar to postischemic reperfusion injury (105).

Diving headache. Divers may develop hypercapnia due to strenuous exercise, breath-holding, or shallow breathing, and affected divers may develop symptoms of CO₂ intoxication. Although diving headache is common, more serious complications include arterial gas embolism, decompression sickness, or barotrauma. Intravascular bubbling can cause activation of plasma kinins and subsequent inflammatory changes consisting of vasodilation, edema formation, and leukocyte chemotaxis, as well as increased blood viscosity (19). Intracerebral bubbles form an arterial gas embolism when gas enters the blood, forced into solution by increased pressure at depth, and is separated from solution during ascent and decompression. Unless exhaled, this gas forms bubbles in the venous system. Bubbles impair microcirculation, damage endothelium, activate complement, and increase blood viscosity. Fat emboli can form secondary to protein denaturation and release fatty acids from cell membranes.

The greatest change in gas volume secondary to pressure changes seems to occur within the first 5 meters from the surface, although arterial gas embolism could occur even at a depth of only 1 meter (19).

Hypoglycemic and fasting-related headache. Hypoglycemia alone is an unlikely cause of fasting headache because hepatic glycogen is usually sufficient for 24 hours, and most of the fasting-related headaches start within the first 18 hours (76; 06). Caffeine withdrawal contributed to fasting headache in some populations with high, chronic use of such products (06), but not in others (76).

Headache associated with dialysis. Headache is extremely common in hemodialysis settings, occurring in 30% to 70% of patients (39). Although chronic headache is common in patients with renal failure, there is a strong correlation between hypotension and dialysis disequilibrium syndrome. Following hemodialysis, CSF pressure generally rises, regardless of whether symptoms of dialysis disequilibrium syndrome are present or not. Elevated CSF pressures may be due to increases in intracranial volumes of CSF or blood, cerebral edema, or any combination thereof. The rate of removal of urea from the brain closely parallels its rate of removal from plasma, but the clearance of urea from CSF is delayed, which probably accounts for the formation of an osmotic gradient between CSF and plasma following hemodialysis. This osmotic gradient leads to a net movement of water into the CSF, raising its pressure. Elevated CSF pressure, although not necessarily associated with brain edema, may contribute to some symptoms of dialysis disequilibrium syndrome, including headache, emesis, and nausea (59). Other pathophysiological considerations for dialysis headache are elevated serum urea and higher systolic and diastolic blood pressures at the onset of hemodialysis (39). Hemodialysis may also precipitate caffeine withdrawal and should be considered a potential cause of headache in heavy caffeine users (77).

Headache attributed to arterial hypertension. Disorders of headache associated with acute hypertension have considerable overlap. These include headache attributed to preeclampsia or eclampsia, hypertensive crisis with or without encephalopathy, autonomic dysreflexia, pheochromocytoma, and posterior reversible encephalopathy syndrome. There may also be a link between these disorders and reversible cerebral vasoconstriction syndrome (29). It is important to recognize that acute changes in blood pressure are more likely to cause headache than chronic hypertension. Thunderclap headache may be a clue to underlying complications, such as cerebral vasoconstriction in secondary headache (eg, pheochromocytoma) (30).

Airplane headache. Case reports note a high prevalence of unilateral tearing and other localized parasympathetic symptoms, with relatively low rates of nausea, photophobia, or phonophobia. One hypothesis is that airplane headache is due to an imbalance between intrasinus and external air pressures and sinus pathology, causing barotrauma (71). Other studies suggest local inflammation, such as prostaglandins or cortisol secretion during flight, as potential causes (13).

Cardiac cephalalgia. The cause may be related to neural convergence with somatic and sympathetic impulses converging in the spinal cord or transient increases of intracardiac pressure increasing intracranial pressure (110).

Epidemiology

Hypoxic headache. Headache is the most common complication of travel to high altitude. Approximately 80% of patients will develop headache at altitudes above 2000 meters (93). The incidence of acute mountain sickness at altitudes between 11,000 ft and 18,000 ft under identical circumstances varies from 1.01 to 83.3 per 1000 (95). The incidence of acute mountain sickness at altitudes between 1850 and 2750 m (7000 to 9000 ft) was found to be 22% and 42% at 3000 m (10,000 ft) in Summit County, Colorado (43). No significant gender difference in the susceptibility to acute mountain sickness has been documented, and physical fitness does not seem to be protective. A personal history of migraine increases the risk of high-altitude headache (16).

Hypoglycemic and fasting-related headache. Headache associated with fasting does not show a significant gender difference. A personal history of headache or migraine predisposes to fasting headache (23).

Headache associated with dialysis. Two large prospective studies of newly hemodialyzed patients found incidence rates of 48% and 70% (03; 39). The disorder occurs at all ages but appears to be more common among younger patients, particularly children (41). Male sex and high pre-dialysis blood pressure may also increase the risk (40).

Headache attributed to airplane travel. Previously considered a rare disorder, airplane headache may be more common than previously realized. A prospective study of medical students found a prevalence of 7.5% (80/1070) for each trip and 14.2% (22/155) of the passengers, especially during takeoff or landing (17/22; 77.3%), with most occurrences reported as stabbing headaches lasting less than 30 minutes (66). Many subjects experienced headache only in a minority of flights, rather than with each flight.

Prevention

Treating the underlying metabolic disorder resolves the associated headaches in most cases. More specific measures are needed in certain situations.

High-altitude headache. Prevention of acute high-altitude headache includes gradual ascent, sleeping at altitudes as low as possible, remaining at the same altitude if symptoms appear, and further ascent only after symptoms resolve (24). Measures should be taken to avoid direct ascent to an altitude of more than 2750 m. Alcohol and drugs that depress ventilation, such as benzodiazepines, should be avoided. Phlebotomy is usually effective for patients with chronic mountain sickness (01). For patients who take longer to acclimatize, there are a few medications that may prevent complications such as mountain sickness or high-altitude headache:

Acetazolamide. Acetazolamide is a carbonic anhydrase inhibitor that causes bicarbonate diuresis and metabolic acidosis and reduces cerebrospinal fluid production. Acetazolamide 250 mg every 8 hours for 2 days before and during the ascent (50) or 125 mg to 250 mg twice daily for 1 day before ascent and for 2 days at high altitude (43) reduces the risk of acute mountain sickness. The lowest effective daily dose is 250 mg (69). In a clinical trial, acetazolamide 125 mg twice daily was relatively more effective than ibuprofen 600 mg three times daily for preventing altitude sickness, with significantly higher peripheral capillary oxygen saturations (14).

Aspirin. In one study, three doses of 320 mg aspirin every 4 hours, taken respectively 2 hours before reaching high altitude, proved beneficial in headache prevention in subjects resting or exercising, without improving oxygenation (15).

Dexamethasone. Dexamethasone is a corticosteroid that reduces capillary permeability and cytokine release, important for the treatment of high-altitude cerebral edema. Dexamethasone has been used prophylactically in doses of 4 mg every 6 hours for 48 hours prior to ascending to 4300 m elevation (57). In a separate study, dexamethasone prevented mountain sickness in soldiers undergoing rapid ascent from sea level to 4400 m (44), but recurrent symptoms after stopping were common.

Ginkgo biloba. Hackett and Roach reported that Ginkgo biloba 160 mg twice daily reduced the intensity and incidence of symptoms by 50% during an abrupt ascent to 4100 m (43). However, the benefit of Gingko biloba for preventing acute mountain sickness and high-altitude headache remains controversial, with one study finding limited therapeutic value (36).

Clonidine. A single study of clonidine 0.2 mg/day showed promising results in preventing acute mountain sickness (43).

Nifedipine. In one trial, a 20 mg extended-release preparation of nifedipine was more effective than placebo in preventing high-altitude pulmonary edema in subjects with a proven history of the disorder. Nifedipine was superior in terms of symptom score, pulmonary artery pressure, and alveolar-arterial pressure gradient (07).

Gabapentin. A study of 600 mg gabapentin at 3500 m in 204 subjects reduced headache severity but not incidence compared to placebo (54).

Sumatriptan. In a study of 102 adults, sumatriptan 50 mg given 1 hour before ascent reduced the incidence of headache and acute mountain sickness compared with placebo (55).

Phosphodiesterase type 5 inhibitors. Phosphodiesterase type 5 inhibitors, including sildenafil and tadalafil, are oral medications used to treat erectile dysfunction and may be effective as a treatment for pulmonary hypertension (04). Although headache is a common side effect of treatment with these medications, they may help reduce hypoxia and increase exercise capacity at high altitudes (37).

Headache associated with obstructive sleep apnea. A few studies report better outcomes after successful treatment of sleep apnea in headache and pain, especially in terms of pain severity (17).

Headache associated with dialysis. Our understanding of hemodialysis pathophysiology and clinical experience provides us with treatment recommendations. Bicarbonate-containing dialyzing solutions (neutralized dialysate) are better tolerated than acetate-containing solutions; they prevent hypoxemia and adjust pH better. Shorter-duration hemodialysis may be beneficial because significant headache-causing accumulations of acetaldehyde may occur during acetate dialysis, especially in patients with impaired metabolizing capacity for acetate. Finally, there may be some benefit in lowering the dialysate temperature (97). Avoiding excessive ultrafiltration can be effective. Effective kidney transplantation may either improve or cure headache in patients with renal failure, not only in those with headache associated with dialysis (108).

Headache attributed to autonomic dysreflexia. Antihypertensives such as terazosin and prazosin may reduce the incidence of episodes (34).

Fasting headache. Fasting is a fairly reliable trigger of migraine in many individuals. In certain circumstances, such as fasting for religious reasons, the use of preemptive acute treatment before migraine onset may prevent migraine. In a study of 71 subjects, those taking frovatriptan 5 mg before a 20-hour fast had fewer headaches than placebo, although results did not reach statistical significance (64). Another study of 189 patients compared the Cox-2 inhibitor etoricoxib 90 mg to placebo taken before a 15-hour Ramadan fast for the first 2 weeks (28). Patients taking etoricoxib had fewer headaches during the 2-week study period than placebo (0.86 mean vs. 1.60 placebo, p = 0.003). A similar study of fasting headache associated with a 25-hour Yom Kippur fast found that subjects using etoricoxib 120 mg were less likely to develop any headache and had less severe headache (27).

Management

High-altitude headache. Mild cases respond to analgesics, hydration, supplemental oxygen, and halting the ascent. When the symptoms persist, or if moderate-severe acute mountain sickness develops, descent to lower altitudes becomes essential. Avoiding medications that decrease respiratory drive, such as opioids or benzodiazepines, is recommended (43). In addition to preventive treatments mentioned above, multiple treatment options have been evaluated for the acute treatment of high-altitude headache:

Dexamethasone. Dexamethasone 4 mg every 6 hours is superior to placebo for treating high-altitude headache and can be used orally, intramuscularly, or intravenously for relatively short periods of time (44) and may also reduce the risk of pulmonary edema and improve exercise tolerance.

Acetazolamide. Although effective in preventing acute mountain sickness, acetazolamide may or may not be effective after the onset of symptoms. Several studies suggest it may be effective for the treatment of chronic mountain sickness with doses of as little as 250 mg/day (109).

Furosemide. Furosemide is a potent loop diuretic that may treat acute mountain sickness by reducing cerebral or pulmonary edema. A few small studies suggest doses of 40 to 80 mg are effective, but given that it may cause dehydration, it is typically used acutely, not preventively (51). Spironolactone 100 mg/day is not effective in acute mountain sickness (08).

Nonsteroidal anti-inflammatories. Nonsteroidal anti-inflammatories, including ibuprofen 400 mg (12) and acetaminophen 1000 mg (47), effectively treat high-altitude headache.

Sumatriptan. Sumatriptan may be effective in treating acute high-altitude headache. A randomized clinical trial of sumatriptan 100 mg among mountaineers demonstrated a transient reduction in the severity of high-altitude headache in the first 3 hours after treatment but similar headache scores after 3 hours (103).

Metoclopramide. Metoclopramide 10 mg may be effective for treating both headache and nausea in those ascending to high altitudes.

Sleep apnea headache. Treatment consists of continuous positive air pressure or surgical treatment of the obstruction.

Diving headache. In most cases, diving headache is relatively benign (19). In more serious cases, such as decompression illness, treatment includes early use of 100% oxygen and recompression in a hyperbaric chamber.

Headache associated with dialysis. In several studies, dialysis headache has been treated by adding either hyperosmotic or hyperoncotic solute (glucose, glycerol, albumin, urea, fructose, sodium chloride, mannitol) to the dialysis solution or by substituting sodium bicarbonate for sodium lactate (or acetate) in the dialysis (84). Studies of uremic patients undergoing hemodialysis, with glycerol or mannitol added to the dialysate, suggest that these agents lessen the symptoms of increased intracranial pressure that may be associated with dialysis disequilibrium syndrome. Sodium ramping can decrease the overall number of side effects occurring during hemodialysis but increases interdialysis symptoms, including weight gain and hypertension (89). Sodium balancing and ultrafiltration techniques effectively decrease the adverse reactions, including headache, in patients undergoing dialysis (02). Dialysis headaches have also been reported to improve with the use of ACE-inhibitors but not with angiotensin II receptor blockers (65).

Headache associated with hypertensive disorders. Although few significant trials compare interventions in hypertensive emergencies, it is generally recommended to reduce blood pressure by no more than 25% within the first hour and then to 160/100 to 110 mm Hg within 2 to 6 hours (21). An assessment for secondary causes of hypertension, such as kidney or heart failure, eclampsia, stroke, arterial dissection, or pheochromocytoma, is recommended. In many scenarios, the treatment is based on the suspected cause of the problem:

In most acute ischemic stroke or arterial dissection settings, rapid lowering of blood pressure is not recommended. Nitroprusside, in particular, should not be used due to its potential to worsen intracranial edema (99).

In pre-eclampsia and eclampsia, the definitive treatment is delivery of the fetus. However, intravenous medications such as labetalol, hydralazine, or magnesium can be used (99).

Avoid using beta-blockers alone to treat pheochromocytoma and other states of catecholamine excess because they could cause unopposed alpha-adrenergic stimulation and additional peripheral vasoconstriction, worsening the hypertension. Intravenous phentolamine is a first-line option (99).

The acute treatment of autonomic dysreflexia includes moving to a sitting position if the person is supine, removing or loosening constrictive clothing or devices, and evaluating for bladder distension and bowel impaction. Although treating the underlying trigger is important, rapid-acting antihypertensives may be necessary to treat acute episodes. Nifedipine, phenoxybenzamine, β-adrenergic blockers, and clonidine may be effective.

References

01: Adams E, Peel T. Chronic mountain sickness: a comprehensive review of current management and proposals for novel therapies. High Alt Med Biol 2025;26(3):318-27. PMID 40329926
02: Al-Hilali N, Al-Humoud HM, Ninan VT, Nampoory MR, Ali JH, Johny KV. Profiled hemodialysis reduced intradialytic symptoms. Transplant Proc 2004;36(6):1827-8.
03: Antoniazzi AL, Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Headache and hemodialysis: A prospective study. Headache 2003;43(2):99-102. PMID 12558762
04: Archer SL, Michelakis ED. Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension. N Engl J Med 2009;361(19):1864-71. PMID 19890129
05: Arngrim N, Schytz HW, Hauge MK, Ashina M, Olesen J. Carbon monoxide may be an important molecule in migraine and other headaches. Cephalalgia 2014;34(14):1169-80. PMID 24816616
06: Awada A, Al Jumah M. The first-of-Ramadan headache. Headache 1999;39:490-3. PMID 11279933
07: Bartsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med 1991;325(18):1284-9. PMID 1922223
08: Basnyat B, Holck PS, Pun M, et al. Spironolactone does not prevent acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial by SPACE Trial Group (spironolactone and acetazolamide trial in the prevention of acute mountain sickness group). Wilderness Environ Med 2011;22(1):15-22. PMID 21377114
09: Baumgartner RW, Siegel AM, Hackett PH. Going high with preexisting neurological conditions. High Alt Med Biol 2007;8(2):108-16. PMID 17584004
10: Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB. Chronic daily headache: identification of factors associated with induction and transformation. Headache 2002;42(7):575-81. PMID 12482208
11: Bolay H, Gül A, Baykan B. COVID-19 is a real headache! Headache 2020;60(7):1415-21. PMID 32412101
12: Broome JR, Stoneham MD, Beeley JM, Milledge JS, Hughes AS. High altitude headache: treatment with ibuprofen. Aviat Space Environ Med 1994;65(1):19-20. PMID 8117220
13: Bui SBD, Gazerani P. Headache attributed to airplane travel: diagnosis, pathophysiology, and treatment - a systematic review. J Headache Pain 2017;18(1):84. PMID 28815436
14: Burns P, Lipman GS, Warner K, et al. Altitude sickness prevention with ibuprofen relative to acetazolamide. Am J Med 2019;132(2):247-51. PMID 30419226
15: Burtscher M, Likar R, Nachbauer W, Schaffert W, Philadelphy M. Ibuprofen versus sumatriptan for high-altitude headache. Lancet 1995;346:354-5. PMID 7616830
16: Burtscher M, Mairer K, Wille M, Broessner G. Risk factors for high-altitude headache in mountaineers. Cephalalgia 2011;31(6):706-11. PMID 21220379
17: Charokopos A, Card ME, Gunderson C, Steffens C, Bastian LA. The association of obstructive sleep apnea and pain outcomes in adults: a systematic review. Pain Med 2018;19(suppl_1):S69-S75. PMID 30203008
18: Chen SP, Fuh JL, Yu WC, Wang SJ. Cardiac cephalalgia. Case report and review of the literature. Eur Neurol 2004;51(4):221-6. PMID 15159603
19: Cheshire WP. Headache and facial pain in scuba divers. Curr Pain Headache Rep 2004;8(4):315-20. PMID 15228893
20: Cheshire WP, Ott MC. Headache in divers. Headache 2001;41(3):235-47. PMID 11264683
21: Chobanian A, Bakris G, Black H, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289(19):2560-72. PMID 12748199
22: Daleau P, Morgado DC, Iriarte CA, Desbiens R. New epilepsy seizure at high altitude without signs of acute mountain sickness or high altitude cerebral edema. High Alt Med Biol 2006;7(1):81-3. PMID 16544970
23: Dalkara T, Kiliç K. How does fasting trigger migraine? A hypothesis. Curr Pain Headache Rep 2013;17(10):368. PMID 23996724
24: Dickinson JG. High altitude cerebral edema: cerebral acute mountain sickness. Semin Respir Infect 1983;151:151.
25: Di Prinzio RR, Arnesano G, Meraglia I, Magnavita N. Headache in workers: a matched case-control study. Eur J Investig Health Psychol Educ 2022;12(12):1852-66. PMID 36547031
26: Dong XY, Bai CB, Nao JF. Clinical and radiological features of posterior reversible encephalopathy syndrome in patients with pre-eclampsia and eclampsia. Clin Radiol 2017;72(10):887-95. PMID 28797767
27: Drescher MJ, Alpert EA, Zalut T, Torgovicky R, Wimpfheimer Z. Prophylactic etoricoxib is effective in preventing Yom Kippur headache: a placebo-controlled double-blind and randomized trial of prophylaxis for ritual fasting headache. Headache 2010;50(8):1328-34. PMID 20039959
28: Drescher MJ, Wimpfheimer Z, Abu Khalef S, Gammaitoni A, Shehadeh N, Torgovicky R. Prophylactic etoricoxib is effective in preventing "first of Ramadan" headache: a placebo-controlled double-blind and randomized trial of prophylactic etoricoxib for ritual fasting headache. Headache 2012;52(4):573-81. PMID 21848948
29: Edvardsson B, Persson S. Reversible cerebral vasoconstriction syndrome associated with autonomic dysreflexia. J Headache Pain 2010;11(3):277-80. PMID 20186562
30: English SW, Nasr DM. Thunderclap headache and cerebral vasoconstriction secondary to pheochromocytoma. JAMA Neurol 2019;76(4):502-3. PMID 30801609
31: Facchinetti F, Allais G, D'Amico R, Benedetto C, Volpe A. The relationship between headache and preeclampsia: a case-control study. Eur J Obstet Gynecol Reprod Biol 2005;121(2):143-8. PMID 16054953
32: Frank F, Kaltseis K, Filippi V, Broessner G. Hypoxia-related mechanisms inducing acute mountain sickness and migraine. Front Physiol 2022;13:994469. PMID 36148300
33: Fujimaki T, MatsutaniM, Asai A, Kohno T, Koike M. Cerebral venous thrombosis due to high-altitude polycythemia. Case report. J Neurosurg 1986;64(1):148-50. PMID 3941339
34: Furlan JC. Headache attributed to autonomic dysreflexia: an underrecognized clinical entity. Neurology 2011;77(8):792-8. PMID 21860009
35: Gami AS, Somers VK. Implications of obstructive sleep apnea for atrial fibrillation and sudden cardiac death. J Cardiovasc Electrophysiol 2008;19(9):997-1003. PMID 18373598
36: Gertsch JH, Basnyat B, Johnson EW, Onopa J, Holck P. Randomized, double blind, placebo controlled comparison of gingko biloba and acetazolamide for prevention of acute mountain sickness among Himalayan Trekkers: The Prevention of High Altitude Illness Trial (PHAIT). BMJ 2004;328(7443):797-806. PMID 15070635
37: Ghofrani HA, Reichenberger F, Kohstall MG, et al. Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial. Ann Intern Med 2004;141(3):169-77. PMID 15289213
38: Gipponi S, Venturelli E, Rao R, Liberini P, Padovani A. Hypertension is a factor associated with chronic daily headache. Neurol Sci 2010;31 Suppl 1:S171-3. PMID 20464615
39: Goksan B, Karaali-Savrun F, Ertan S, Savrun M. Haemodialysis-related headache. Cephalalgia 2004;24(4):284-7. PMID 15030537
40: Gozubatik-Celik G, Uluduz D, Goksan B, et al. Hemodialysis-related headache and how to prevent it. Eur J Neurol 2019;26(1):100-5. PMID 30102816
41: Grushkin CM, Korsch B, Fine RN. Hemodialysis in small children. JAMA 1972;221:869-71. PMID 4558793
42: Gus M, Fuchs FD, Pimentel M, Rosa D, Melo AG, Moreira LB. Behavior of ambulatory blood pressure surrounding episodes of headache in mildly hypertensive patients. Arch Intern Med 2001;161(2):252-5. PMID 11176740
43: Hackett PH, Roach RC. High-altitude illness. N Engl J Med 2001;345(2):107-14. PMID 11450659
44: Hackett PH, Roach RC, Wood RA, et al. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med 1988;59(10):950-4. PMID 3190622
45: Hafeez F. Acute complications of haemodialysis in paediatric age group. J Coll Physicians Surg Pak 2005;15(5):280-3. PMID 15907238
46: Hagen K, Bjoro T, Zwart JA, Vatten L, Stovner LJ, Bovim G. Low headache prevalence amongst women with high TSH values. Eur J Neurol 2001;8(6):693-9. PMID 11784355
47: Harris NS, Wenzel RP, Thomas SH. High altitude headache: efficacy of acetaminophen vs. ibuprofen in a randomized, controlled trial. J Emerg Med 2003;24(4):383-7. PMID 12745039
48: Harrison MF, Anderson P, Miller A, et al. Oral contraceptive use and acute mountain sickness in South Pole workers. Aviat Space Environ Med 2013;84(11):1166-71. PMID 24279230
49: Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33(9):629-808. PMID 23771276
50: Houston CS. High altitude illness. JAMA 1976;236:2193-5. PMID 989810
51: Hultgren HN. Letter: Furosemide for high altitude pulmonary edema. JAMA 1975;234(6):589-90. PMID 1242183
52: Hwang J, Lim YH, Eun MY, et al. Lower glucose level associated with increased risk for post-dural puncture headache. Headache 2020;60(9):1901-9. PMID 32463126
53: Jackson SJ, Varley J, Sellers C, et al. Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro. High Alt Med Biol 2010;11(3):217-22. PMID 20919888
54: Jafarian S, Abolfazli R, Gorouhi F, Rezaie S, Lotfi J. Gabapentin for prevention of hypobaric hypoxia-induced headache: randomized double-blind clinical trial. J Neurol Neurosurg Psychiatry 2008;79:321-3. PMID 17965148
55: Jafarian S, Gorouhi F, Salimi S, Lotfi J. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial. Ann Neurol 2007;62(3):273-7. PMID 17557349
56: Jassal DS, McGinn G, Embil JM. Pituitary apoplexy masquerading as meningoencephalitis. Headache 2004;44(1):75-8 PMID 14979887
57: Johnson TS, Rock PB, Fulco CS, Trad LA, Spark RF, Maher JT. Prevention of acute mountain sickness by dexamethasone. N Engl J Med 1984;310:683. PMID 6700643
58: Katz JN, Gore JM, Amin A, et al. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J 2009;158(4):599-606. PMID 19781420
59: Kennedy AC, Linton AL, Renfrew S. The pathogenesis and prevention of cerebral dysfunction during dialysis. Lancet 1964;1:790-3. PMID 14108004
60: Khan FA, McIntyre C, Khan AM, Maslov A. Headache and methemoglobinemia. Headache 2020;60(1):291-7. PMID 31724752
61: Krassioukov AV, Bunge RP, Pucket WR, Bygrave MA. The changes in human spinal sympathetic preganglionic neurons after spinal cord injury. Spinal Cord 1999;37(1):6-13. PMID 10025688
62: Kruszewski P, Bieniaszewski L, Neubauer J, Krupa-Wojciechowska B. Headache in patients with mild to moderate hypertension is generally not associated with simultaneous blood pressure elevation. J Hypertens 2000;18(4):437-44. PMID 10779095
63: Kundin JE. Yom Kippur headache. Neurology 1996;47(3):854. PMID 8797506
64: Latsko M, Silberstein S, Rosen N. Frovatriptan as preemptive treatment for fasting-induced migraine. Headache 2011;51(3):369-74. PMID 21269298
65: Leinisch-Dahlke E, Schmidt-Wilcke T, Kramer BK, May A. Improvement of dialysis headache after treatment with ACE-inhibitors but not angiotensin II receptor blocker: a case report with pathophysiological considerations. Cephalalgia 2005;25(1):71-4. PMID 15606574
66: Lima GA, Vasconcelos Júnior FC, Morais IM, et al. Prevalence of headache attributed to airplane travel among medical students in Brazil. Headache 2020;60(10):2406-12. PMID 32997811
67: Lindan R, Joiner E, Freehafer AA, Hazel C. Incidence and clinical features of autonomic dysreflexia in patients with spinal cord injury. Paraplegia 1980;18(5):285-92. PMID 7443280
68: Litch JA, Bishop RA. Transient global amnesia at high altitude. N Engl J Med 1999;340(18):1444. PMID 10328714
69: Low EV, Avery AJ, Gupta V, Schedlbauer A, Grocott MP. Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis. BMJ 2012;345:e6779. PMID 23081689
70: Maghbooli M, Jameshorani M, Afshar S, Kamali K. The prevalence of metabolic syndrome parameters and their association with headache characteristics among migraineurs. Curr J Neurol 2021;20(4):190. PMID 38011412
71: Mainardi F, Lisotto C, Maggioni F, Zanchin G. Headache attributed to airplane travel ('airplane headache'): clinical profile based on a large case series. Cephalalgia 2012;32(8):592-9. PMID 22492425
72: Mainardi F, Maggioni F, Zanchin G. Aeroplane headache, mountain descent headache, diving ascent headache. Three subtypes of headache attributed to imbalance between intrasinusal and external air pressure? Cephalalgia 2018;38(6):1119-27. PMID 28786693
73: Man YH, Meng XL, Yu TM, Yao G. Pacemaker implantation for treating migraine-like headache secondary to cardiac arrhythmia: a case report. Medicine (Baltimore) 2018;97(50):e13629. PMID 30558049
74: Mohsenin V. Sleep in chronic obstructive pulmonary disease. Semin Respir Crit Care Med 2005;26(1):109-16. PMID 16052423
75: Moreau T, Manceau E, Giroud-Baleydier F, Dumas R, Giroud M. Headache in hypothyroidism. Prevalence and outcome under thyroid hormone therapy. Cephalalgia 1998;18(10):687-9. PMID 9950626
76: Mosek A, Korczyn AD. Yom Kippur headache. Neurology 1995;45:1953-5. PMID 7501139
77: Nikic PM, Zidverc-Trajković J, Andrić B, Milinković M, Stojimirović B. Caffeine-withdrawal headache induced by hemodialysis. J Headache Pain 2009;10(4):291-3. PMID 19367462
78: Ozkan B, Cayir A, Kosan C, Alp H. Cystinosis presenting with findings of Bartter syndrome. J Clin Res Pediatr Endocrinol 2011;3(2):101-4. PMID 21750641
79: Ozge A, Ozge C, Kaleagasi H, et al. Headache in patients with chronic obstructive pulmonary disease: effects of chronic hypoxaemia. J Headache Pain 2006;7(1):37-43. PMID 16408153
80: Pappu R, Jabbour SA, Reginato AM, Reginato AJ. Musculoskeletal manifestations of primary hyperparathyroidism. Clin Rheumatol 2016;35(12):3081-7. PMID 27815654
81: Parfrey PS, Foley RN, Wittreich BH, Sullican DJ, Zagaru MJ, Frei D. Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. J AM Soc Nephrol 2005. PMID 15901766
82: Picone O, Castaigne V, Ede C, Fernandez H. Cerebral metastases of a choriocarcinoma during pregnancy. Obstet Gynecol 2003;102(6):1380-3. PMID 14662230
83: Porcelli MJ, Gugelchuk GM. A trek to the top: a review of acute mountain sickness. J Am Osteopath Assoc 1995;95(12):718-20. PMID 8557556
84: Port FK, Johnson WJ, Klass DW. Prevention of dialysis disequilibrium syndrome by use of high sodium concentration in the dialysate. Kidney Int 1973;3:327-33. PMID 4792047
85: Post TE, Denney C, Cohen A, Jordan J, Limper U. Human hypoxia models in aerospace medicine: potential applications for human pharmacological research. Br J Clin Pharmacol 2026;92(1):58-72. PMID 38556349
86: Roach RC, Hackett PH. Frontiers of hypoxia research: acute mountain sickness. J Exp Biol 2001;204:3161-70. PMID 11581330
87: Robbins MS, Farmakidis C, Dayal AK, Lipton RB. Acute headache diagnosis in pregnant women: a hospital-based study. Neurology 2015;85(12):1024-30. PMID 26291282
88: Ronen R, Zhou D, Bafna V, Haddad GG. The genetic basis of chronic mountain sickness. Physiology (Bethesda) 2014;29(6):403-12. PMID 25362634
89: Sang GL, Kovithavongs C, Ulan R, Kjellstrand CM. Sodium ramping in hemodialysis: a study of beneficial and adverse effects. Am J Kidney Dis 1997;29:669-77. PMID 9159299
90: Serrano-Duenas M. High altitude headache. A prospective study of its clinical characteristics. Cephalalgia 2005;25(12):1110-6. PMID 16305599
91: Shah AK. Non-aneurysmal primary subarachnoid hemorrhage in pregnancy induced hypertension and eclampsia. Neurology 2003;61(1):117-20. PMID 12847171
92: Shen Y, Zhang J, Yang J, et al. Association of EPAS1 and PPARA gene polymorphisms with high-altitude headache in Chinese Han population. Biomed Res Int 2020;2020:1593068. PMID 32185192
93: Silber E, Sonnenber P, Collier DJ, Pollard AJ, Murdoch DR, Goadsby PJ. Clinical features of headache at altitude: A prospective study. Neurology 2003;60(7):1167-71. PMID 12682326
94: Silva-Néto RP, Soares AA, Peres MF. Hypnic headache due to hypoglycemia: a case report. Headache 2019;59(8):1370-3. PMID 31498893
95: Singh L, Khanna P, Srivastava MG, Lal M, Roy SB, Subramanyam CS. Acute mountain sickness. N Engl J Med 1969;280:175-84.
96: Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol 2004;61(3):411-6. PMID 15023819
97: Sousa Melo E, Carrilho Aguiar F, Sampaio Rocha-Filho PA. Dialysis headache: a narrative review. Headache 2017;57(1):161-4. PMID 27349210
98: Sperling JD, Dahlke JD, Huber WJ, Sibai BM. The role of headache in the classification and management of hypertensive disorders in pregnancy. Obstet Gynecol 2015;126(2):297-302. PMID 26241418
99: Suneja M, Sanders ML. Hypertensive emergency. Med Clin North Am 2017;101(3):465-78. PMID 28372707
100: Sutton JR, Coates G, Houston CS. The Lake Louise consensus on the definition and quantification of altitude illness. In: Sutton JR, Coates G, Houston CS, editors. Hypoxia and mountain medicine. Burlington: Queen City Printers, 1992.
101: Sutton JR, Houston CS, Mansell AL. Effect of acetazolamide on hypoxemia during sleep at high altitude. N Engl J Med 1979;301:1329. PMID 503151
102: Thomas JE, Rooke ED, Kvale WF. The neurologist's experience with pheochromocytoma. A review of 100 cases. JAMA 1966;197(10):754-8. PMID 5953366
103: Utiger D, Eichenberger U, Bernasch D, Baugartner RW, Bartsch P. Transient minor improvement of high altitude headache by sumatriptan. High Alt Med Biol 2002;3 (4):387-93. PMID 12631424
104: van Oosterhout WP, Perenboom MJ, Terwindt GM, Ferrari MD, Vein AA. Frequency and clinical features of space headache experienced by astronauts during long-haul space flights. Neurology 2024;102(7):e209224. PMID 38478846
105: Varon J, Marik P, Fromm R, Gueler A. Carbon monoxide poisoning: a review for clinicians. J Emerg Med 1999;17:87-93. PMID 9950394
106: Vein AA, Koppen H, Haan J, Terwindt GM, Ferrari MD. Space headache: a new secondary headache. Cephalalgia 2009;29(6):683-6. PMID 19175610
107: Virmani SK, Swamy AS. Cranial nerve palsy at high altitude. J Assoc Physicians India 1993;41(7):460. PMID 8300498
108: Viticchi G, Falsetti L, Buratti L, et al. Headache and kidney transplantation: an intriguing relationship. Neurol Sci 2019;40(Suppl 1):199-200. PMID 30903413
109: Wang Y, Han Z, Feng Z. The efficacy and safety of acetazolamide in chronic mountain sickness: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2025;20(3):e0319689. PMID 40100807
110: Wei JH, Wang HF. Cardiac cephalalgia: case reports and review. Cephalalgia 2008;28(8):892-6. PMID 18505457
111: Wilson MH, Davagnanam I, Holland G, et al. Cerebral venous system and anatomical predisposition to high-altitude headache. Ann Neurol 2013;73(3):381-9. PMID 23444324
112: Wolff HG, Lennox WG. Cerebral circulation: 12. The effect on pial vessels of variation in the oxygen and carbon dioxide content of the blood. Arch Neurol Psychiatry 1930;23:1097.
113: Yin X, Li Y, Ma Y, et al. Thickened retinal nerve fiber layers associated with high-altitude headache. Front Physiol 2022;13:864222. PMID 35600299

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Michael J Marmura MD

Dr. Marmura of Thomas Jefferson University received research support from AbbVie, Axome, and Lundbeck and consulting honorariums from Impel and Lumbeck.
See Profile

Editor

Shuu-Jiun Wang MD

Dr. Wang of National Yang-Ming University and Taipei Veterans General Hospital received research grants from AbbVie, Lundbeck, Pfizer, Novartis, and Orient Europharma as principal investigator. He received speaker honorariums from AbbVie, Biogen, Eli Lilly, Hava Biopharma, and Pfizer.
See Profile

Former Authors

John Stirling Meyer MD
Shizuko Konno MD
Alexandru N Nitu MD DC
Simon P Kim MD
Nabih M Ramadan MD
Lori B Siegel MD

Patient Profile

Age range of presentation: 2 to 65+ years
Sex preponderance: female>male, >1:1
Heredity: none
Population groups selectively affected: none selectively affected
Occupation groups selectively affected: none selectively affected

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Headache attributed to disorders of homeostasis

Associated Disorders

Chronic respiratory failure
Diabetes mellitus
Dialysis disequilibrium syndrome
Mountain sickness

Differential Diagnosis

acute stroke
subdural hematoma
subarachnoid hemorrhage
uremic encephalopathy
infections
- hyponatremia
- acute psychosis
- arteriovenous malformation
- brain tumor
- carbon monoxide poisoning
- CNS infection
- dehydration
- diabetic ketoacidosis
- exhaustion
- hangover
- hypoglycemia
- hypothermia
- ingestion of toxins
- migraine
- seizure
- hyponatremia

Also Relevant

Decompression sickness: neurologic manifestations
Headache associated with acute substance use or exposure
Headache in transplant patients
Mountain sickness: neurologic aspects
Carbon monoxide poisoning: neurologic aspects

Disorder	Supportive diagnostic testing
Carbon monoxide poisoning	Increased carboxyhemoglobin level, metabolic acidosis.
Sleep apnea	Sleep study demonstrating apnea events.
Hypertensive crisis, eclampsia, or preeclampsia	Consider angiography for suspected cerebral reversible vasoconstrictive syndrome or MRI for possible infarction.
Autonomic dysreflexia	Increased blood pressure should correlate with episodes. Look for an inciting event, such as a urinary tract infection.
Pheochromocytoma	Plasma metanephrines or 24-hour urine metabolites. CT or MRI to localize the tumor.
Hypothyroidism	Increased TSH and low serum free T4.
Cardiac cephalgia	EKG, stress test, coronary angiography. Nitroglycerin helps headache.

Headache attributed to disorders of homeostasis …

Headache attributed to disorders of homeostasis

Cite this article

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Table 1. Diagnostic Testing for Disorders of Homeostasis

Management

Special considerations

Pregnancy

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Suzetrigine

Atogepant

Indomethacin-responsive headache syndromes

Cluster headache

Headache associated with HIV and AIDS

Primary exercise headache

Chiropractic manipulation: neurologic complications

Refractory migraine

Headache attributed to disorders of homeostasis

Cite this article

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Prognosis and complications

Clinical vignette

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Diagnostic workup

Table 1. Diagnostic Testing for Disorders of Homeostasis

Management

Special considerations

Pregnancy

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Suzetrigine

Atogepant

Indomethacin-responsive headache syndromes

Cluster headache

Headache associated with HIV and AIDS

Primary exercise headache

Chiropractic manipulation: neurologic complications

Refractory migraine

This is an article preview.
Start a Free Account
to access the full version.